secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0000012208-24-000031
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad Life Science Group President Simon May resigns; James Barry appointed as successor
--------------------------------------------------------------------------------

- Simon May resigns as EVP & President, Life Science Group, effective May 1, 2024, to pursue another opportunity.
- James J. Barry promoted from SVP of Global Manufacturing to succeed May as EVP & President, Life Science Group, effective May 1, 2024.
- Stockholders approved amendment to 2017 Incentive Award Plan, extending expiration to 2034 and allowing non-employee director participation.
- Principal accounting officer role transferred to CFO Roop K. Lakkaraju, replacing interim Tania DeVilliers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220824000031/0000012208-24-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220824000031/bio-20240422.htm
  HTML page:      https://secwatch.observer/filing/0000012208-24-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer